4DM-61942-16039
3 vaccinations
3 coded responses
17 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 149 / NY
- Registered
- 2021-01-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Moderna
-
2021-01-20
Registered in v-safe
-
2021-01-20
Dose 2 — Moderna
-
2021-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
-
2021-04-21
Survey response — 3 months, dose 2MedDRA: Dysphonia, Pyrexia — Feeling: Fair · Be unable to workFree text: My voice went extremely hoarse & low grade fever yesterday. I was potentially exposed ten days ago. If symptoms continue, Ill obtain a Covid test tomorrow.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-21
-
2021-10-27
Dose 3 — Moderna
-
2022-01-20
Survey response — 12 months, dose 2MedDRA: Headache, Lethargy, Pyrexia, Sinus congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Five days after exposure, developed sudden onset of symptoms on 12/20-low grade fever, general lethargy, sinus congestion & headache 5 days. Rapid test on 12/22 was negative. Stayed out the week & returned to work 12/27/21.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-26
- 2022-04-27
-
2022-10-27
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVID positive on 9/14/22MedDRA releases: 2024-11 · check-in free text available
-
2022-10-27
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-10-28
Call successfulNot applicable - Accidental Reporting
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Moderna | |
| 2 | 2021-01-20 | Moderna | |
| 3 | 2021-10-27 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 7 — 3 months, dose 2
Symptoms: My voice went extremely hoarse & low grade fever yesterday. I was potentially exposed ten days ago. If symptoms continue, Ill obtain a Covid test tomorrow.
Release 10 — 12 months, dose 2
Symptoms: Five days after exposure, developed sudden onset of symptoms on 12/20-low grade fever, general lethargy, sinus congestion & headache 5 days. Rapid test on 12/22 was negative. Stayed out the week & returned to work 12/27/21.
Release 12 — 12 months, dose 3
Symptoms: COVID positive on 9/14/22
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Dysphonia | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Sinus congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release